Advertisement -- Learn more about ads on this site.

Health A-Z

Medical Content Created by the Faculty of the
Harvard Medical School

Prognosis

Many people with single-system Langerhans' cell histiocytosis recover completely. While many people with multisystem disease respond to chemotherapy, the condition may be fatal in severe or resistant cases.

People with Langerhans' cell histiocytosis may have a higher-than-average risk of developing cancer later in life, including lymphoma and leukemia. The reason for this increased risk is not known.

Click here to to redeem your SparkPoints
  You will earn 3 SparkPoints
From Health A-Z, Harvard Health Publications. Copyright 2007 by the President and Fellows of Harvard College. All rights reserved. Written permission is required to reproduce, in any manner, in whole or in part, the material contained herein. To make a reprint request, contact Harvard Health Publications. Used with permission of StayWell.

You can find more great health information on the Harvard Health Publications website.